InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Deardorf Caren, Directeur Commercial. Officer active across 2 companies, notably Magenta Therapeutics, Inc.. Cumulatively, 8 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €36k. History available since 14 September 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Deardorf Caren
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,925 sharesCommon StockSEC:0001628280-26-044721:0
6,900 shares0Common StockSEC:0000950170-25-086269:0
3,400 shares0Common StockSEC:0000950170-24-071931:0
6,000 shares0Common StockSEC:0001209191-23-038823:0
3,000 shares@ US$0.943.6% of flowCommon StockSEC:0000899243-22-037432:0
3,000 shares@ US$0.996.7% of flowCommon StockSEC:0000899243-22-021185:0
6,238 shares@ US$6.7386.6% of flowCommon StockSEC:0000899243-21-036600:0
20,000 shares0Common StockSEC:0000899243-21-036338:0
8 of 8 declarations
About Deardorf Caren
Deardorf Caren is Directeur Commercial and appears in 8 filings in total. Across the 8 sampled recent filings, the transactions cover the period from 2021-09-16 to 2026-06-22, with EUR 0 of buys and EUR 35,676 of sells, mainly related to Magenta Therapeutics, Inc. and Crinetics Pharmaceuticals, Inc.
